Randomized phase II trial of rubidazone (Rubi) and adriamycin (Adr) in women with advanced breast cancer

J. N. Ingle, D. L. Ahmann, H. F. Bisel

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)No. C-564
JournalProceedings of the American Association for Cancer Research
VolumeVol. 20
StatePublished - Jan 1 1979

ASJC Scopus subject areas

  • General Medicine

Cite this